Skip to main content
. 2016 Mar 7;7(4):275–282. doi: 10.1136/flgastro-2015-100651

Table 3.

Proportion (%) of subjects with abnormal results by age

Biomarker 18–49 50–69 70+
Pancreatic elastase* 9.2 16.8 23.1
Calprotectin** 9.7 12.0 17.8
Eosinophil protein X* 7.2 9.0 17.0
Low growth of Bifido/Lacto*** 62.9 69.3 62.6

Age distribution of abnormal results for biomarkers with significant differences by age.

Across-group significance: *p<0.0001; **p=0.0009; ***p<0.0025.